Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy (2021)
Attributed to:
MICA: Optimising combination strategies for chimeric antigen receptor therapy in multiple myeloma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17441
PubMed Identifier: 34323287
Publication URI: http://europepmc.org/abstract/MED/34323287
Type: Journal Article/Review
Parent Publication: British Journal of Haematology
Issue: 5
ISSN: 0007-1048